Morbidity and Outcomes of Primary Tumor Management in Patients with Widely Metastatic Well-Differentiated Small Bowel Neuroendocrine Tumors

被引：0
|
作者：
Aradhya Nigam
Janet W. Y. Li
Megan Fiasconaro
Sabrina Lin
Marinela Capanu
David A. Kleiman
Kelvin Memeh
Nitya Raj
Diane L. Reidy-Lagunes
Brian R. Untch
机构：
[1] Memorial Sloan Kettering Cancer Center,Department of Surgery
[2] Memorial Sloan Kettering Cancer Center,Department of Epidemiology and Statistics
[3] Lahey Hospital and Medical Center,Department of Surgery
[4] Memorial Sloan Kettering Cancer Center,Department of Medicine
来源：
Annals of Surgical Oncology | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2337 / 2348
页数：11
相关论文
共 50 条
  • [41] Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors
    Reidy, Diane L.
    Tang, Laura H.
    Saltz, Leonard B.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (03): : 143 - 152
  • [42] Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors
    Liu, A.
    Ueberroth, B.
    McGarrah, P.
    Petty, S. A. Buckner
    Kendi, A.
    Starr, J.
    Hobday, T.
    Halfdanarson, T. R.
    Sonbol, M. B.
    PANCREAS, 2021, 50 (03) : 448 - 448
  • [43] A Case of Cushing's Syndrome from Well-Differentiated Neuroendocrine Tumors of the Small Bowel and Its Mesentery
    Carlaw, Kirsten Rose
    Hameed, Ahmer
    Shakeshaft, Anthony
    CURRENT ONCOLOGY, 2023, 30 (04) : 4110 - 4116
  • [44] Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
    Li, Su-Chen
    Essaghir, Ahmed
    Martijn, Cecile
    Lloyd, Ricardo V.
    Demoulin, Jean-Baptiste
    Oberg, Kjell
    Giandomenico, Valeria
    MODERN PATHOLOGY, 2013, 26 (05) : 685 - 696
  • [45] Systemic Therapy for Tumor Control in Well-Differentiated Metastatic Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline Q and A
    Del Rivero, Jaydira
    Kennedy, Erin B.
    Perez, Kimberley
    JCO ONCOLOGY PRACTICE, 2023, 19 (11) : 955 - +
  • [46] Outcomes of Cytoreductive Surgery for Well-Differentiated Metastatic Neuroendocrine Tumors in the Setting of Extra-Hepatic Metastases
    Hallet, J.
    Koujanian, S.
    Beyfuss, K.
    Coburn, N.
    Karanicolas, P.
    Law, C.
    NEUROENDOCRINOLOGY, 2016, 103 : 97 - 98
  • [47] Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors
    Sharma, Nancy
    Naraev, Boris G.
    Engelman, Eric G.
    Zimmerman, M. Bridget
    Bushnell, David L., Jr.
    O'Dorisio, Thomas M.
    O'Dorisio, M. Sue
    Menda, Yusuf
    Mueller-Brand, Jan
    Howe, James R.
    Halfdanarson, Thorvardur R.
    PANCREAS, 2017, 46 (02) : 151 - 156
  • [48] The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors
    Hindie, Elif
    THERANOSTICS, 2017, 7 (05): : 1159 - 1163
  • [49] Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors
    Dogan, Izzet
    Tastekin, Didem
    Karabulut, Senem
    Sakar, Burak
    JOURNAL OF DIGESTIVE DISEASES, 2022, 23 (8-9) : 493 - 499
  • [50] Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
    Strosberg, Jonathan R.
    Fisher, George A.
    Benson, Al B.
    Anthony, Lowell B.
    Arslan, Bulent
    Gibbs, John F.
    Greeno, Edward
    Iyer, Renuka V.
    Kim, Michelle K.
    Maples, William J.
    Philip, Philip A.
    Wolin, Edward M.
    Cherepanov, Dasha
    Broder, Michael S.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (08) : 2450 - 2459
12345